Correlation Between Capri Holdings and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capri Holdings and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capri Holdings and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capri Holdings and Mydecine Innovations Group, you can compare the effects of market volatilities on Capri Holdings and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capri Holdings with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capri Holdings and Mydecine Innovations.

Diversification Opportunities for Capri Holdings and Mydecine Innovations

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Capri and Mydecine is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Capri Holdings and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Capri Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capri Holdings are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Capri Holdings i.e., Capri Holdings and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Capri Holdings and Mydecine Innovations

Given the investment horizon of 90 days Capri Holdings is expected to under-perform the Mydecine Innovations. But the stock apears to be less risky and, when comparing its historical volatility, Capri Holdings is 13.98 times less risky than Mydecine Innovations. The stock trades about -0.01 of its potential returns per unit of risk. The Mydecine Innovations Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.50  in Mydecine Innovations Group on September 24, 2024 and sell it today you would lose (0.10) from holding Mydecine Innovations Group or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Capri Holdings  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Capri Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capri Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Mydecine Innovations 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Capri Holdings and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capri Holdings and Mydecine Innovations

The main advantage of trading using opposite Capri Holdings and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capri Holdings position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Capri Holdings and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes